Suppr超能文献

利用 CRISPR 分析网络工具在严重早发性肥胖症患者来源的 iPSCs 中进行高效 Cas9 基因组编辑。

Efficient Cas9-based Genome Editing Using CRISPR Analysis Webtools in Severe Early-onset-obesity Patient-derived iPSCs.

机构信息

Columbia Stem Cell Initiative, Stem Cell Core, Columbia University Irving Medical Center, New York, New York.

Spanish National Cancer Research Center, Madrid, Spain.

出版信息

Curr Protoc. 2022 Aug;2(8):e519. doi: 10.1002/cpz1.519.

Abstract

The CRISPR system is an adaptive defense mechanism used by bacteria and archaea against viruses and plasmids. The discovery of the CRISPR-associated protein Cas9 and its RNA-guided cleavage mechanism marked the beginning of a new era in genomic engineering by enabling the editing of a target region in the genome. Gene-edited cells or mice can be used as models for understanding human diseases. Given its high impact in functional genomic experiments on different model systems, several CRISPR/Cas9 protocols have been generated in the past years. The technique uses a straightforward "cut and stitch" mechanism, but requires an accurate step-by-step design. One of the key points is the use of an efficient programmable guide RNA to increase the rate of success in obtaining gene-specific edited clones. Here, we describe an efficient editing protocol using a ribonucleotide protein (RNP) complex for homology-directed repair (HDR)-based correction of a point mutation in an induced pluripotent stem cell (iPSC) line generated from a 14-year-old patient with severe early-onset obesity carrying a de novo variant of ARNT2. The resulting isogenic iPSC line, named CUIMCi003-A-1, has a normal karyotype, expresses stemness markers, and can be differentiated into progenies from all three germ layers. We provide a detailed workflow for designing a single guide RNA and donor DNA, and for isolating clonal human iPSCs edited with the desired modification. This article also focuses on parameters to consider when selecting reagents for CRISPR/Cas9 gene editing after testing their efficiency with in silico tools. © 2022 The Authors. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Design of sgRNAs and PCR primers Basic Protocol 2: Testing the efficiency of sgRNAs Basic Protocol 3: Design of template or donor DNA Basic Protocol 4: Targeted gene editing Basic Protocol 5: Selection of positive clones Basic Protocol 6: Freezing, thawing, and expansion of cells Basic Protocol 7: Characterization of edited cell lines.

摘要

CRISPR 系统是细菌和古菌用来对抗病毒和质粒的一种适应性防御机制。CRISPR 相关蛋白 Cas9 的发现及其 RNA 引导的切割机制的发现,标志着基因组工程新纪元的开始,使人们能够编辑基因组中的靶标区域。基因编辑细胞或小鼠可用作理解人类疾病的模型。鉴于其在不同模型系统的功能基因组实验中的高影响力,过去几年已经产生了几种 CRISPR/Cas9 方案。该技术使用一种简单的“切割和拼接”机制,但需要精确的分步设计。关键点之一是使用高效的可编程向导 RNA 来提高获得基因特异性编辑克隆的成功率。在这里,我们描述了一种使用核糖核蛋白 (RNP) 复合物进行同源定向修复 (HDR) 的有效编辑方案,以纠正从携带 ARNT2 从头变异的 14 岁严重早发性肥胖患者中产生的诱导多能干细胞 (iPSC) 系中的点突变。所得的同基因 iPSC 系命名为 CUIMCi003-A-1,具有正常核型,表达干细胞标志物,并且可以分化为来自所有三个胚层的后代。我们提供了一个详细的工作流程,用于设计单个向导 RNA 和供体 DNA,并用于分离用所需修饰编辑的克隆人 iPSC。本文还侧重于在通过计算机工具测试其效率后选择用于 CRISPR/Cas9 基因编辑的试剂时要考虑的参数。© 2022 作者。Wiley Periodicals LLC 出版的《当代协议》。基本方案 1:sgRNA 和 PCR 引物的设计基本方案 2:sgRNA 效率的测试基本方案 3:模板或供体 DNA 的设计基本方案 4:靶向基因编辑基本方案 5:阳性克隆的选择基本方案 6:细胞的冷冻、解冻和扩增基本方案 7:编辑细胞系的特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ca/12016462/8091ac783cc8/CPZ1-2-0-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验